Holotropic Breathwork vs MDMA-Assisted Therapy

A side-by-side comparison of recorded mechanisms, evidence review status, related condition topics, and philosophical roots.

At a glance

Source checks, condition-specific assessments and expert review are separate steps. Each assessment applies only to its stated population and use. Topic links do not establish comparative effectiveness.

Holotropic Breathwork

Tradition
Psychedelic
Founder
Stanislav Grof / Christina Grof (1976)
Review status
Assessment not yet completed
Focus
Experiential + Integration
Format
Group (workshop format); individual adaptations exist
Duration
Full-day workshops or multi-day intensives; individual sessions less common

MDMA-Assisted Therapy

Tradition
Psychedelic
Founder
MAPS / Mithoefer (2021)
Review status
4 source checks available
Official sources
Guidelines and official sources (4)

3 clinical guideline checks · 1 regulatory source check

Read the recommendation and its scope. A source may discuss an approach without recommending it.

  • NDA 215455: midomafetamine complete response letter

    US Food and Drug Administration · 2024-08-08; Reference ID 5427030 · Regulatory source · Complete response issues 1–3, pages 1–4; additional comments pages 5–6

    Not a treatment recommendation

    The letter verifies the 2024 nonapproval decision and identifies safety reporting, durability and bias concerns. Psychotherapy-contribution questions appear separately as additional comments.

    Scope: Midomafetamine application NDA 215455 for PTSD

    Source checked

  • Clinical Practice Guideline for Management of PTSD and Acute Stress Disorder

    VA/DoD · 2023 · Clinical guideline · Recommendation 23; Table 6, p.37

    Insufficient evidence for or against

    VA/DoD finds insufficient evidence for or against MDMA-assisted psychotherapy. The guideline’s evidence cutoff precedes later trials and regulatory decisions.

    Scope: MDMA-assisted psychotherapy for adults with PTSD; evidence reviewed through May 2022.

    Source checked

  • Management of Major Depressive Disorder

    VA/DoD · Version 4.0, February 2022; evidence through January 2021 · Clinical guideline · Recommendation 35; pp.26,67–68

    Recommendation against the stated use

    VA/DoD strongly recommends against MDMA for MDD outside research. This 2022 guideline used evidence through January 2021; it does not assess later trials or every diagnosis.

    Scope: MDMA for MDD outside research settings.

    Source checked

  • Clinical Practice Guideline for the Treatment of Posttraumatic Stress Disorder in Adults

    American Psychological Association · Approved February 2025; 2025 update · Clinical guideline · Psychedelic interventions, printed p.14 (PDF p.18)

    Insufficient evidence for or against

    APA finds insufficient evidence for or against this intervention in the reviewed comparisons.

    Scope: Adults with PTSD; MDMA-assisted psychotherapy versus the inactive or low-dose active comparators reviewed.

    Source checked

Focus
Experiential + Processing
Format
Individual (co-therapist)
Duration
Short (3 sessions)

How they work

Holotropic Breathwork

Core mechanism: Altered breathing pattern induces non-ordinary state that bypasses ordinary ego defenses, allowing access to perinatal, biographical, and transpersonal material that can be processed and integrated through somatic release, imagery, and mandala drawing

Ontology: The psyche as multi-layered: biographical, perinatal (birth trauma), and transpersonal, with healing available at all levels through non-ordinary states that transcend ordinary rational consciousness

MDMA-Assisted Therapy

Core mechanism: MDMA reduces the fear response and increases trust and empathy, making it possible to stay with trauma material inside the therapeutic relationship

Ontology: PTSD maintained by overwhelming fear that prevents therapeutic engagement; MDMA lowers this barrier pharmacologically

Related condition topics

These editorial cross-references organize reading. A shared link does not mean both approaches are effective, recommended, or interchangeable for that condition.

2 shared · 4 Holotropic Breathwork-only · 0 MDMA-Assisted Therapy-only

What each assumes — and misses

Holotropic Breathwork

Philosophical roots: Grof's cartography of the psyche (COEX systems, BPM matrices); James (varieties of religious experience); Jung (collective unconscious, archetypes); Maslow (peak experiences, transpersonal psychology); Perennial philosophy

Blind spots: No controlled research base; contraindications are significant and screening is essential; transpersonal framework not accepted by mainstream clinical psychology; risk of retraumatization without adequate support; facilitator quality varies widely outside certified programs; not suitable for many clinical populations

Therapeutic voice: Breathe faster and deeper than you normally would, and then stop steering. Whatever comes up is what needed to come up. Your sitter stays with you the whole time.

MDMA-Assisted Therapy

Philosophical roots: Mithoefer (inner healing intelligence); Rogers (organismic wisdom, given conditions); Buber (I-Thou enabled pharmacologically); trauma processing theory

Blind spots: FDA declined approval (2024); methodological concerns about unblinding; not currently legally available outside research

Therapeutic voice: You're safe here. If something difficult comes up, you can move toward it. You don't have to do this alone.

Choosing between them

Holotropic Breathwork and MDMA-Assisted Therapy both sit within the Psychedelic tradition — they share a worldview about what suffering is and how change happens. Differences are more often about technique and emphasis than about underlying theory.

For deeper coverage: see the full Holotropic Breathwork and MDMA-Assisted Therapy pages, or use the interactive comparison tool to add more modalities to this comparison.